Actively Recruiting
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
Led by University Hospital Tuebingen · Updated on 2026-01-26
50
Participants Needed
1
Research Sites
152 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a prospective, single-center, observational proof-of-principle clinical trial at the Department of Women's Health of the University Hospital Tübingen.
CONDITIONS
Official Title
Non-Invasive Plasma Treatment for Cervical Infections: Targeting High- and Low-Risk HPV Variants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 18 years or older
- HPV infection confirmed by mRNA or DNA testing from a smear or swab
- Clearly visible transformation zone of the cervix and lesion margins corresponding to T1/T2
- Written informed consent to participate in the study
You will not qualify if you...
- Transformation zone of the cervix not fully visible
- Evidence of invasive disease
- Serious cardiovascular diseases
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University Hospital Tuebingen, Department of Women's Health
Tübingen, Germany, 72076
Actively Recruiting
Research Team
M
Martin Weiss, Dr. med.
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here